India, Oct. 28 -- image credit- freepik

Hyderabad-based Nucelion Therapeutics, a next-generation Cell and Gene Therapy CDMO and wholly owned subsidiary of Bharat Biotech, and Bengaluru-headquartered Pandorum Technologies, a Tissue Engineering and Regenerative Medicine company, have announced that their manufacturing partnership will advance two PRIP-backed ophthalmology projects focused on developing investigational therapies for advanced keratopathy and wet age-related macular degeneration (wet AMD).

Pandorum is developing cell-free regenerative medicines based on designer exosomes that carry biological signals involved in communication between cells. The biological activity of these exosomes is tuned to address inflammation, fibrosis ...